RISK OF ADVERSE LIVER AND RENAL OUTCOMES AFTER INITIATION OF A SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITOR VS. GLP-1 RECEPTOR AGONISTS AND DIPEPTIDYL PEPTIDASE-4 INHIBITORS AMONG US ADULT PATIENTS WITH TYPE 2 DIABETES AND MASLD
HEPATOLOGY（2023）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要